Effects of Tibetan medicine Longdan zhike tablet on chronic obstructive pulmonary disease through MAPK pathway

慢性阻塞性肺病 医学 药理学 慢性支气管炎 传统医学 中医药 支气管炎 呼吸系统 替代医学 内科学 病理
作者
Yulin Feng,Pengfei Qin,Rong Wang,Yahui Mi,You Li,Jiahao Feng,Wen-Bin Shen,Haijuan Dong,Jietai Duo,Liming Ma,Xiaowu Yao,Xiaolong Hu,Fei Xiong,Xinhong Shi,Hao Wang
出处
期刊:Journal of Ethnopharmacology [Elsevier BV]
卷期号:328: 118082-118082
标识
DOI:10.1016/j.jep.2024.118082
摘要

Longdan zhike tablet (LDZK) is a Tibetan medicine formula commonly used in the highland region of Tibet, China, to ameliorate respiratory diseases, such as acute bronchitis and asthma. In Chinese traditional medicine, some herbal formulas with anti-inflammatory properties targeting the respiratory system are clinically adopted as supplementary therapies for chronic obstructive pulmonary disease (COPD). However, the specific anti-COPD effects of LDZK remain to be evaluated. The aim of this study is to identify the principal bioactive compounds in LDZK, and elucidate the effects and mechanisms of the LDZK on COPD. High-resolution mass spectrometry was utilized for a comprehensive characterization of the chemical composition of LDZK. The therapeutic effects of LDZK were assessed on the LPS-papain-induced COPD mouse model, and LPS-induced activation model of A549 cells. The safety of LDZK was evaluated by orally administering a single dose of 30 g/kg to rats and monitoring physiological and biochemical indicators after a 14-day period. Network pharmacology and Western blot analysis were employed for mechanism prediction of LDZK. A comprehensive analysis identified a total of 45 compounds as the major constituents of LDZK. Oral administration of LDZK resulted in notable ameliorative effects in respiratory function, accompanied by reduced inflammatory cell counts and cytokine levels in the lungs of COPD mice. Acute toxicity tests demonstrated a favorable safety profile at a dose equivalent to 292 times the clinically prescribed dose. In vitro studies revealed that LDZK exhibited protective effects on A549 cells by mitigating LPS-induced cellular damage, reducing the release of NO, and downregulating the expression of iNOS, COX2, IL-1β, IL-6, and TNF-α. Network pharmacology and Western blot analysis indicated that LDZK primarily modulated the MAPK signaling pathway and inhibited the phosphorylation of p38/ERK/JNK. LDZK exerts significant therapeutic effects on COPD through the regulation of the MAPK pathway, suggesting its potential as a promising adjunctive therapy for the treatment of chronic inflammation in COPD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
淇淇发布了新的文献求助10
刚刚
1秒前
科研通AI2S应助xs采纳,获得10
2秒前
2秒前
研友_VZG7GZ应助Yoo采纳,获得30
2秒前
3秒前
exing完成签到,获得积分10
3秒前
BINGBING发布了新的文献求助10
4秒前
5秒前
思源应助落后的采波采纳,获得10
5秒前
5秒前
Tian_lanlan完成签到,获得积分10
6秒前
jingwen发布了新的文献求助10
6秒前
6秒前
幸福安白完成签到,获得积分10
6秒前
7秒前
7秒前
7秒前
叶子完成签到,获得积分10
7秒前
卡卡西应助橙子采纳,获得30
8秒前
8秒前
CDKSEVEN发布了新的文献求助10
8秒前
8秒前
fj关闭了fj文献求助
8秒前
Zachary完成签到,获得积分10
9秒前
10秒前
李爱国应助邪恶小天使采纳,获得10
11秒前
无梦为安发布了新的文献求助10
11秒前
刘仁轨发布了新的文献求助10
11秒前
11秒前
12秒前
12秒前
12秒前
养虎人发布了新的文献求助10
12秒前
hrrypeet完成签到,获得积分10
13秒前
111完成签到,获得积分10
13秒前
范范完成签到,获得积分20
13秒前
NexusExplorer应助meng采纳,获得10
13秒前
14秒前
行者完成签到,获得积分10
14秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975165
求助须知:如何正确求助?哪些是违规求助? 3519595
关于积分的说明 11198781
捐赠科研通 3255912
什么是DOI,文献DOI怎么找? 1798001
邀请新用户注册赠送积分活动 877343
科研通“疑难数据库(出版商)”最低求助积分说明 806298